Caribou Biosciences

AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
Best Stocks
AbbVie
Caribou Biosciences
CRISPR
Flag link:
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
Motley Fool
Caribou Biosciences
cell therapy
CB-010
relapsed or refractory B cell lymphoma
Flag link:
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
cell therapy
Caribou Biosciences
CRISPR Therapeutics
Flag link:
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
BioSpace
Caribou Biosciences
CAR-T
CB-010
B-cell non-Hodgkin lymphoma
cell therapy
Flag link:
Pfizer pours $25M investment into Caribou's cell therapies
Pfizer pours $25M investment into Caribou's cell therapies
Fierce Biotech
Pfizer
Caribou Biosciences
gene editing
CAR-T
Multiple Myeloma
Flag link:
BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice
BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice
Fierce Biotech
BIO 2023
Caribou Biosciences
lymphoma
CRISPR
cell therapy
Flag link:
Caribou gets FDA fast track for allogeneic CAR-T
Caribou gets FDA fast track for allogeneic CAR-T
Biopharma Reporter
Caribou Biosciences
FDA
Multiple Myeloma
CAR-T
CB-011
Flag link:
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
Fierce Biotech
Caribou Biosciences
CRISPR
CAR-T
allogenic CAR-T
EHA
non-Hodgkin's lymphoma
Flag link:
EHA 2022 preview – some good news at last
EHA 2022 preview – some good news at last
EP Vantage
EHA
Caribou Biosciences
CB-010
Gracell
Autolus
Roche
Curocell
ADC Therapeutics
Mustang Bio
Flag link:
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
MedCity News
IPOs
cell therapy
artificial intelligence
Sana Biotechnology
Lyell Immunopharma
Caribou Biosciences
Instil Bio
Talaris Therapeutics
Achilles Therapeutics
Flag link:
Biotech listings show signs of a slowdown
Biotech listings show signs of a slowdown
EP Vantage
IPOs
Adagio Therapeutics
Caribou Biosciences
Erasca
DiCE Therapeutics
Icosavax
Flag link:
Caribou raises $304M in one of gene editing's most lucrative IPOs
Caribou raises $304M in one of gene editing's most lucrative IPOs
BioPharma Dive
Caribou Biosciences
CRISPR
gene editing
IPOs
Flag link:
The incubator that hatched a Jennifer Doudna CRISPR startup blueprints new 'destination for life science entrepreneurship'
The incubator that hatched a Jennifer Doudna CRISPR startup blueprints new 'destination for life science entrepreneurship'
EP Vantage
Caribou Biosciences
Zymergen
incubators
QB3
Jennifer Doudna
Flag link:
Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR
Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR
BioSpace
Caribou Biosciences
CRISPR
Flag link:
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
BioPharma Dive
Caribou Biosciences
Jennifer Doudna
CRISPR
gene editing
Flag link:
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
AbbVie
Editas Medicine
CRISPR
Caribou Biosciences
gene editing
Flag link:
Living the CRISPR dream
Living the CRISPR dream
Pharmaforum
Caribou Biosciences
gene editing
CRISPR
Flag link:
At 31, she runs one of the hottest biotech companies in the country
At 31, she runs one of the hottest biotech companies in the country
Stat
CRISPR
Caribou Biosciences
Flag link:
Novartis moves into genome editing with collaboration deal
Novartis moves into genome editing with collaboration deal
Seeking Alpha
Novartis
genome editing
Intellia Therapeutics
Caribou Biosciences
Flag link: